정맥 혈전용해술과 관련된 뇌출혈에 대한 지혈치료 후 뇌경색이 악화된 증례
Progression of Acute Ischemic Infarction after a Hemostatic Therapy for Thrombolysis-Related Intracerebral Hemorrhage
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
As thrombolysis for acute ischemic stroke is a double-edged sword, so could be the hemostatic treatment for thrombolysis-induced intracerebral hemorrhage. An 88-year-old woman with acute ischemic stroke presented with severe dysarthria and right hemiparesis. Her neurological symptoms rapidly improved after intravenous tissue plasminogen activator (t-PA) treatment. However, she became drowsy one hour after the intravenous t-PA treatment. Brain CT revealed a small right thalamic hemorrhage which was contralateral to the initial ischemic lesion. To prevent expansion of the hematoma, vitamine K was infused intravenously. Three hours after the infusion, conjugate eyeball deviation to the left side and right hemiplegia developed, which were likely to be resulted from reocclusion. Hemostatic therapy, such as vitamine K infusion, might be related to the worsening of cerebral ischemia after recanalization with t-PA. (Korean J Stroke 2011;13:41-44)
Abstract
As thrombolysis for acute ischemic stroke is a double-edged sword, so could be the hemostatic treatment for thrombolysis-induced intracerebral hemorrhage. An 88-year-old woman with acute ischemic stroke presented with severe dysarthria and right hemiparesis. Her neurological symptoms rapidly improved after intravenous tissue plasminogen activator (t-PA) treatment. However, she became drowsy one hour after the intravenous t-PA treatment. Brain CT revealed a small right thalamic hemorrhage which was contralateral to the initial ischemic lesion. To prevent expansion of the hematoma, vitamine K was infused intravenously. Three hours after the infusion, conjugate eyeball deviation to the left side and right hemiplegia developed, which were likely to be resulted from reocclusion. Hemostatic therapy, such as vitamine K infusion, might be related to the worsening of cerebral ischemia after recanalization with t-PA. (Korean J Stroke 2011;13:41-44)
참고문헌 (10)
- Jüttler E, "Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhage", Circulation, 98, pp.1376~1382 (1998)
- Broderick J, "Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association", American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group, 2007, pp.38, 2001~2023
- Brott T, "Early hemorrhage growth in patients with intracerebral hemorrhage", Stroke, 28, pp.1~5 (1997)
- Diringer MN, "Thromboembolic events with recombinant activated factor VII in spontaneous intracerebral hemorrhage: results from the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial", Stroke, 41, pp.48~53 (2010)
- Goldstein JN, "Management of thrombolysis-associated symptomatic intracerebral hemorrhage", Arch Neurol, 67, pp.965~969 (2010)
- Marder V, "Thrombolytic therapy, in Consultative Hemostasis and Thrombosis. 2nd ed", pp.491~501 (2007), Elsevier
- "Algorithm for Management of Intracranial Hemorrhage Following Thrombolytic Therapy for Stroke"[URL]
- Alexandrov AV, "Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator", Neurology, 59, pp.862~867 (2002)
- Lubetsky A, "Comparison of oral vs Intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study", Arch Intern Med, 163, pp.2469~2473 (2003)
- Yiu KH, "Comparison of the efficacy and safety profiles of intravenous vitamin K and fresh frozen plasma as treatment of warfarin-related over-anticoagulation in patients with mechanical heart valves", Am J Cardiol, 97, pp.409~411 (2006)